News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Andy Cowan appointed as President of Particle Measuring Systems and he will report to Mark Fleiner, President Spectris Scientific and Malvern Panalytical

Belfast-based techbio company AMPLY Discovery Limited has raised over £1.4m in grant funding to develop new drug products using its proprietary AI-driven drug discovery platform.

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease

PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment Clinical Trial Application filed for combined drug targeting amyloid deposits as...

Biocair, a distinguished life science logistics company with over three decades of expertise, was announced as the winner of two awards at the esteemed Asia-Pacific Cell & Gene Therapy Excel...

University of Liverpool Life Sciences Employability Week (w/c 6th November 2023)

PharmaKure, a company specialising in companion diagnostics for the treatment of neurological diseases and APIS Assay Technologies Ltd, a company with scientific expertise in biomarker trans...

Through a series of exclusive interviews and a survey of industry insiders, Connect in Pharma names the top pharmaceutical and manufacturing-related trends of 2023.

In 2017, the UK government introduced the Apprenticeship Levy, a tax on large employers designed to fund apprenticeships and subsidize them for small and medium-sized enterprises (SMEs). onl...

With approval of MHRA to submit a CTA, PharmaKure is now well positioned to advance towards its clinical trial programme that is essential to market authorisation

Biocair has invested heavily in the creation of a specialist logistics team to meet the complex needs of the rapidly expanding cell and gene therapy sector.

In order to ensure a strong future for European pharma, businesses need to prioritise digitalisation and maintain control of production lines, say two speakers at Connect in Pharma.

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners